A coronavirus immunity test is essential for the U.S. But will it work? [Los Angeles Times (CA)]
Biomerica, Inc. (BMRA)
NASDAQ:AMEX Investor Relations:
biomerica.com/company/investor.asp
Company Research
Source: Los Angeles Times
It’s a potential saving grace salvaged from a pandemic: As people recover from the coronavirus, they may develop immunity that could allow them to return to school or work, helping place the U.S. on the road to recovery. But tests to determine whether a person is immune are just being developed in the U.S., and concern is growing that the process could be marred by the same kind of widely criticized delays and confusion that plagued testing aimed at detecting COVID-19. The test, called a serology test, uses blood samples, rather than secretions taken from throats and noses, to check if a person has developed antibodies against the novel coronavirus. Germany may begin wide-spread serology testing in April, and the U.K. has ordered millions of at-home antibody tests. The U.S., by comparison, hasn’t come up with a cohesive plan for large-scale antibody testing, which health experts say could dash chances for a return to public life and leave health officials with few options for managing
Show less
Read more
Impact Snapshot
Event Time:
BMRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRA alerts
High impacting Biomerica, Inc. news events
Weekly update
A roundup of the hottest topics
BMRA
News
- Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis [Yahoo! Finance]Yahoo! Finance
- Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative ColitisGlobeNewswire
- Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements [Yahoo! Finance]Yahoo! Finance
- Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirementsGlobeNewswire
- Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain [Yahoo! Finance]Yahoo! Finance
BMRA
Sec Filings
- 11/14/24 - Form SC
- 11/6/24 - Form 8-K
- 10/15/24 - Form 10-Q
- BMRA's page on the SEC website